ProfileGDS5678 / 1448442_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 98% 99% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 110.378798
GSM967853U87-EV human glioblastoma xenograft - Control 210.471298
GSM967854U87-EV human glioblastoma xenograft - Control 310.741599
GSM967855U87-EV human glioblastoma xenograft - Control 410.840998
GSM967856U87-EV human glioblastoma xenograft - Control 510.566698
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 110.10298
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 29.6350598
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 310.115298
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 410.257698
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 110.460798
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 210.281898
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.518598
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 410.356698
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.44798